Browsing Category
excipients
Vitafoods Barcelona 2025 – with a focus on excipients
This year´s Vitafoods Europe opens its doors in Barcelona at Fira Barcelona Gran Via.
From 20th to 22th May you can have a face-to-face chat with visitors and exhibitors again.
PharmaExcipients gives you an overview of the excipient suppliers, their booths, main topics and products in the…
Read More...
Read More...
Gangwal Healthcare – A solutions provider for Complex, Innovative & Cutting-edge…
Powered By Innovation, Driving Health, Wellness & Healing
The building of a “best in class” solutions provider starts with understanding the complexities of a customer’s need and identifying gaps. New technologies and Drug Delivery Systems are studied and appropriate excipients or raw-materials…
Read More...
Read More...
Recent progress in pharmaceutical excipients as P-glycoprotein inhibitors for potential improvement…
Abstract
Pharmaceutical excipients such as P-glycoprotein inhibitors can also increase the solubility and affinity of drugs to the intestinal membrane, enhance paracellular pathways and endocyte uptake, and activate lymph transport pathways, thereby increasing the bioavailability of oral drugs.…
Read More...
Read More...
50 Novel Drug Approvals by FDA in 2024 – What’s inside?
The FDA approved 50 novel drugs in 2024, marking another milestone year in pharmaceutical innovation. While various summaries have highlighted these approvals, the composition and presentation of these new drug products — encompassing APIs and excipients — are often less explored.
To address…
Read More...
Read More...
The composition of Drugs going off-patent in the upcoming years
As a follow up on the article 𝐖𝐡𝐢𝐜𝐡 𝐝𝐫𝐮𝐠𝐬 𝐰𝐢𝐥𝐥 𝐥𝐨𝐬𝐞 𝐩𝐚𝐭𝐞𝐧𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐦𝐢𝐧𝐠 𝐲𝐞𝐚𝐫𝐬? by Joanna Sadowska, PhD, EMBA in which includes over 30 products going off-patent from 2025 to 2037 we pulled together the dosage form and composition of these products. Please note that the composition may vary in…
Read More...
Read More...
The Role of Excipients In Determining N-Nitrosamine Risks for Drug Products
See the nice infographic prepared by IPEC Federation on the hot topic of Nitrosamine Risk Determination:
THE BACKGROUND
N-nitrosamines are a class of organic compounds, some of which are associated with a potential for a significant carcinogenic risk.
In July 2018, the…
Read More...
Read More...
Call for papers – Excipients: new opportunities for complex challenges
Innovative drug formulations rely not only on active ingredients, but also on excipients. These vital substances enhance drug stability, delivery, and effectiveness, ensuring medications perform as intended and improve patient outcomes.
We are happy to announce that Sharareh Salar-Behzadi,…
Read More...
Read More...
Photo and video recap Pharma Excipients @CPHI Milan 2024
This year´s CPHI Europe happend last week from 8th to 10th October in Milano at Fiera Milano.
.
Pharma Excipients visited the excipients hall, hall 6 for you and in the following you find a broad range of booth photos as well as short introduction videos we recorded at CPhI 2024 in Milan.
Here…
Read More...
Read More...
CPHI Milan 2024 – with a focus on excipients
This year CPHI Europe opens its doors in Milano at Fiera Milano.
From 8th to 10th October you can have a face-to-face chat with visitors and exhibitors again. As usual, InnoPack,
P-MEC, FDF, ICSE, MedTech and BioProduction will be held together with CPHI.
Pharma Excipients gives you an overview…
Read More...
Read More...
Should developers choose a cosmetic or pharmaceutical-grade excipient for topical formulations?
As regulations continue to change around the quality and risk of cosmetic- and pharmaceutical-grade excipients, developers have an important choice to make when investing in quality, risk, and public safety.
Hear from Gloria Ho, the Global Technical Marketing Manager at BASF Pharma Solutions, on…
Read More...
Read More...